{"name":"Abbott Medical Devices","slug":"abbott-medical-devices","ticker":"","exchange":"","domain":"abbottmedicaldevices.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"clopidogrel + aspirin OR prasugrel + aspirin","genericName":"clopidogrel + aspirin OR prasugrel + aspirin","slug":"clopidogrel-aspirin-or-prasugrel-aspirin","indication":"Acute coronary syndrome (STEMI, NSTEMI)","status":"marketed"}]}],"pipeline":[{"name":"clopidogrel + aspirin OR prasugrel + aspirin","genericName":"clopidogrel + aspirin OR prasugrel + aspirin","slug":"clopidogrel-aspirin-or-prasugrel-aspirin","phase":"marketed","mechanism":"This dual antiplatelet therapy combines two P2Y12 inhibitors (clopidogrel or prasugrel) with aspirin to prevent blood clots by blocking platelet aggregation through different pathways.","indications":["Acute coronary syndrome (STEMI, NSTEMI)","Prevention of stent thrombosis after percutaneous coronary intervention","Secondary prevention of cardiovascular events in coronary artery disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOGdLak9XZTBuNENkYnFlaEdWaE5FdVR6aFA4VEQyMHFYcTNKamYwdnRKV0I5UU9YTnhfb1E2ZmMySXlwWkJITXNWdzByRHRTLWVncGZDaGo2ZEt0Tm1IZjdwdk03MXpzSm5ObXFFV0tpYWtLckVOZVRnWEFHZ3RZR1J1QnQ0SE5aeDdTTmdRUEpaem9haWhVZHZsTEpwbXVUWlBqNmRPQnRfRjd1aEJGeVNyZ0g2eWJwNGZMUUhfMFE?oc=5","date":"2026-04-02","type":"regulatory","source":"AD HOC NEWS","summary":"Abbott India Ltd Stock: Steady Growth in India's Pharmaceutical Sector Amid Evolving Healthcare Dema - AD HOC NEWS","headline":"Abbott India Ltd Stock: Steady Growth in India's Pharmaceutical Sector Amid Evolving Healthcare Dema","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1WeFFRUXVTd0VBY1VIa255UUpoUVYxckl2MFFKYkF1R1JKcElJRTI5N2phYUQxODhSRWx2a3JEcnZlSmpMbjlBdFhhUndnS0wzU2U0R19HVnhWYnBWVlhSRmY0dGpCVzdqSWZJMUdnYWN4STd5enJ3QVpn?oc=5","date":"2026-03-11","type":"earnings","source":"Statista","summary":"Abbott Laboratories' segment revenues from 2017 to 2025 - Statista","headline":"Abbott Laboratories' segment revenues from 2017 to 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNOV9RcHJvZVI0Q19RU3lmUjZJSEVrMkgwb2N6MWRmZFlKMEJVeXhHdXpJaDJKZ09tRHRsM0hNYlpxVWpoSUpUWDdhXzRhS2RyQThDdkNNeEh5WXVidVM4eVZvNGhfcWZHV0lfMzVrVlREY3JjeHhVUkVDVFBNcEkzVEw3Y19FWC1odWUycnVqdUQ5U29XMnVKZkx3?oc=5","date":"2026-03-05","type":"pipeline","source":"Pharma Voice","summary":"Cancer tests are becoming more precise and guiding pharma R&D - Pharma Voice","headline":"Cancer tests are becoming more precise and guiding pharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE8xTm5zT3hiNnUtZHd0dUxkLTdmSWFwYVA2Z2VUcjdjbXQtNFBjN0ZwaEJWeW10VU9lTmFxbmJBQXlja0h0anNyMVlBQUotZEY2QUk1MVVhZUVILXpRQ0VjSzhDUnl1dVRqWVRYN2V2OHhnZjhBZGE3bQ?oc=5","date":"2026-02-16","type":"pipeline","source":"Reliable Plant","summary":"Abbott completes $6.2 billion acquisition of Solvay Pharmaceuticals - Reliable Plant","headline":"Abbott completes $6.2 billion acquisition of Solvay Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNaVNPOXZ6M3lJTnFaQzBNaEZkMklBdGs4WktPMUhUTnBiMjIzT1pBT2pZWm4wVkF0X2NXUlB0S3BsdlRCRGVfZzQ1ZzVIbGlOWUhldFhKZ21Xdzk4Q0ZpUmNvUzBOQ25OVjJCSkJUcHdmbzlIcW5KYzBqb1N0b1RsMUhudDIwajZvMm1QcHNZdEFYb2JQZzNzdHFzaVg5cW9ORU9TVldqUDN4WVFEbzZWNFItVFBoLTdobnVxVkNyT0hTMUZULXFLVU03TlFtbGdlOTFsbG9tc2ZHUTZQ?oc=5","date":"2026-02-04","type":"regulatory","source":"Reuters","summary":"US FDA says injuries from Abbott's recalled glucose sensors reach 860 - Reuters","headline":"US FDA says injuries from Abbott's recalled glucose sensors reach 860","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxObTdzY2xoTVNQVDFiUlBKYzJPS2YxVzh3ZTg5SFNDSEU2bGVVUmo3alowNUVucy1JOVlsYWhrRGlSa1EzRG9Sd0lSTThuUno3b05kd1JXQ2VERUlmNHRLUzVlQ0JydmpjWkVmMC1rd1N1RjBYV2ZyY3lraGp4dHY0TW9EZ1ZDUVVQVGFQNTBaYzNkSUY3SkZIaXpMU0UzaUQ0aUNSY3kzTXFYSmMyYzlfbTU0REJDcnZKc0Y4enRn?oc=5","date":"2026-01-23","type":"earnings","source":"Abbott","summary":"Abbott 2025 Results: Double?Digit Earnings Growth | Abbott Newsroom - Abbott","headline":"Abbott 2025 Results: Double?Digit Earnings Growth | Abbott Newsroom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1UMmJNTkZRZ3lUeHgwUWRpcFNzdElSUTFVcVJjQTUyOWRYdnNMWk14bFBUTVlpWDExN01aWUFfbXBvTFdwRU5uNEVFclJSby1PY1RaSjYyUDBjOHpqOWpaSlJR?oc=5","date":"2025-12-04","type":"pipeline","source":"The Pharma Letter","summary":"Abbott - The Pharma Letter","headline":"Abbott","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQSERKTlhyQVA4MjRZNFpCcS1RM1pRSFhZWl85eDIyZXo2MndfZjdhcDhYMGowSC1Na3hGdk5zSVJIM3BOcUtRRGJvcXhMbFd2RDV6X0xxcC1GbjB1SWkxbVBoTFZ5d3c4bEpsLTc3TWtSU2xqUFNrdUo3TWxvNzhRZVpXRVdjaU5yaHRRWWhjaE5mZmNsWGZGQVAwdWI2N09ZQnJuSjlEUVluc21ycVAzSmFtb194R2RxSG8wTnpPbVliQ2F5eWt4LUs1WjhwNmFzV3BlYQ?oc=5","date":"2025-10-15","type":"earnings","source":"Reuters","summary":"Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices lift - Reuters","headline":"Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices lift","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNV3pvRFVRc0lEOTdiNTRqWW5td0hDTXZzbnFoY2tJWkpwc09SS3l0Ny1pN2U5eVFOOC00RURrQUlTN05VTkdtSDI0dHN4eExlZks4Ukp5Qzc2eWdZTUZ4RmdOSHhCMXJFS2dQWWlaVVVRQXowTHI2bHd6Wlg5ZU9LeHJ6b29UU0UzTE5URjdsaEZXYXpNUkpnSEJ3V1l2X2x3VlZROVZVamNZWUM3ckRvM3Fvb1QxMmhJUVVQWHR0cXhReUs4d1NUT0NMVk9fdTJVTUxfTTZwZlMyRmdERmZNVUx3?oc=5","date":"2025-09-30","type":"pipeline","source":"Proactive financial news","summary":"Healthcare equipment stocks seen outperforming, ‘safer’ than Big Pharma: analysts - Proactive financial news","headline":"Healthcare equipment stocks seen outperforming, ‘safer’ than Big Pharma: analysts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPb1VvUGctNl80WGVTZzhaNXAyMnFER2Vodl9mVkY4bGl4Y1E4UnNsSkc0OFlPUktoQTV2WUFkdUtxalRxRjFndkZTRGhQanc2ZDNZanhqY2RtSS1PdVhNdVh0ZHBKRTF2YkN0QVpBZXBmNjYwa0dDWnl0SFJlUEFITVJuMVFENXZsNlBUR0VOMm42Y1pGcHpj?oc=5","date":"2025-09-01","type":"pipeline","source":"Yahoo Finance","summary":"How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance","headline":"How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-17","type":"regulatory","source":"ET Pharma","summary":"Abbott beats estimates on medical devices demand as forecast hits shares - ET Pharma","headline":"Abbott beats estimates on medical devices demand as forecast hits shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQajl5aDVqaXFXYmdlV0ctalIxa3Fac002R2hRbGNLWG5kTkpCcEN1S1VoVV9GTTdCTGk5QUYwZjUyVW9wcDJ3ZEFNRUxZTmw1TDJpbi1FenRTSUttOXNkRkVGSE9NRUVveUlHSTV4S2xvSWRraHFzOTlTM2hUai1DOEU4Qk1wNWFBS0YxRE9LMUZNanZzSU12M2JtelZfR3fSAaQBQVVfeXFMT05zUE92dlFnNWxRY1p0NkswUDhPWldfTnlCbDN1TXlRQUxlUUh2d3lZWlpydElfa2dzcUlWeVk5Y3llQXJEcmV3WlB3Ql9rUUs1Sjk0ekd2bXI5NWxBeVk3VVZDWWN6YmhIOTAwb05yd3I5VUVrVWdibVJmOFZwc3QyUm1Ud0xqMXZpQ1kxcUpaaDMzektEemc2b2F4cjQ3MXZjZG0?oc=5","date":"2025-04-30","type":"pipeline","source":"CNBC","summary":"Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom - CNBC","headline":"Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}